Differences in Visual Acuity After Phacoemulsification in Cataract Patients with Diabetes Mellitus Compared to Cataract Patients without Diabetes Mellitus at Klinik Mata dr. Imam
DOI:
https://doi.org/10.12928/admj.v5i2.10630Keywords:
Visual acuity, Phacoemulsification, Cataract, Diabetes mellitusAbstract
Phacoemulsification is a common cataract surgery to improve visual acuity. Postoperative visual outcomes may be influenced by diabetes mellitus (DM). This study aimed to compare visual acuity outcomes after phacoemulsification in cataract patients with and without DM. It used an analytic observational design with a cross-sectional approach, analyzing medical records of 60 cataract patients (30 with DM, 30 without DM) from Klinik Mata dr. Imam (January 2022–September 2023). Inclusion criteria were patients with and without DM who underwent phacoemulsification and had visual acuity results 21 days post-surgery. Patients using antidiabetic drugs or insulin were included, while those with incomplete medical records, glaucoma, corneal opacities, cataract complications, diabetic retinopathy, macular degeneration, retinal detachment, hypertensive retinopathy, or chronic kidney disease undergoing hemodialysis were excluded. Data were analyzed using the Mann-Whitney test. Results showed visual acuity in both groups mostly fell within the normal category based on WHO standards (6/6–6/18), with 23 (76.7%) patients in the DM group and 27 (90%) in the non-DM group. Statistical analysis indicated no significant difference in visual acuity between groups (p = 0.150). In conclusion, there is no significant difference in postoperative visual acuity between cataract patients with and without DM undergoing phacoemulsification at Klinik Mata dr. Imam.
References
Hashemi H, Pakzad R, Yekta A, et al. Global and regional prevalence of age-related cataract: a comprehensive systematic review and meta-analysis. Eye Journal. 2020;34(8):1357-1370. doi:10.1038/s41433-020-0806-3
WHO. Blindness and vision impairment. Published 2022. Accessed June 11, 2023.
Fang R, Yu YF, Li EJ, et al. Global, regional, national burden and gender disparity of cataract: findings from the global burden of disease study 2019. BMC Public Health. 2022;22(1):1-16. doi:10.1186/S12889-022-14491-0/TABLES/2
Badan Litbangkes Kementerian Kesehatan RI. 2018. Rapid Assessment of Avoidable Blindness (RAAB) di Indonesia. Jakarta: Kemenkes RI
Harianja GM, Fatmawati NK, Sulistiawati. Penurunan Tekanan Intraokular Pascaoperasi Katarak dengan Teknik Fakoemulsifikasi di Klinik Mata SMEC Samarinda. Jurnal Kedokteran Mulawarman. 2020;7(3).
Astari P. Katarak: Klasifikasi, Tatalaksana, dan Komplikasi Operasi. Cermin Dunia Kedokteran. 2018;45(10):748-753.
Julita. Pemeriksaan Tajam Penglihatan pada Anak dan Refraksi Siklopegik: Apa, Kenapa, Siapa? Jurnal Kesehatan Andalas. 2018;7(1). http://jurnal.fk.unand.ac.id
Yong GY, Mohamed-Noor J, Salowi MA, Adnan TH, Zahari M. Risk factors affecting cataract surgery outcome: The Malaysian cataract surgery registry. PLoS ONE Journal. 2022;17(9). doi:10.1371/JOURNAL.PONE.0274939
IDF. International Diabetes Federation Diabetes Atlas. 10th ed.; 2021. www.diabetesatlas.org
WHO. Diabetes. Published 2023. Accessed June 11, 2023. https://www.who.int/health-topics/diabetes#tab=tab_1
Kementerian Kesehatan. Laporan Nasional Riset Kesehatan Dasar.; 2018.
Putra PGW, Sunariasih NN, Ningrum RK. Perbedaan Tajam Penglihatan Pascaoperasi Fakoemulsifikasi Pada Pasien Katarak Dengan Diabetes Melitus dan Tanpa Diabetes Melitus. Aesculapius Medical Journal |. 2022;2(1).
Izzuddin MA, Fatmawati NK, Nugroho H. Perbedaan Tajam Penglihatan Pascaoperasi Fakoemulsifikasi antara Pasien Katarak dengan Diabetes Mellitus dan Tanpa Diabetes Mellitus. Jurnal Medika Karya Ilmiah Kesehatan. 2022;7(2):2541-4615.
Nabila AN. Perbedaan Tajam Penglihatan Pasca Fakoemulsifikasi pada Pasien Katarak Senilis dengan Diabetes Mellitus Non-Retinopati dan tanpa Diabetes Mellitus di Balai Kesehatan Mata Masyarakat (BKMM) Cikampek. Jurnal Penelitian UMJ. 2022;27(1):1-10.
Hidayah A. Perbedaan Tajam Penglihatan Pasca Operasi Fakoemulsifikasi Pada Pasien Katarak Dengan Diabetes Melitus Dan Tanpa Diabetes Melitus Di RS PKU Yogyakarta Unit 1. Universitas Muhammadiyah Yogyakarta; 2015.
Jie LJ, Salowi MA, Adnan TH, Anuar N, Ngah NF, Choo MM. Visual outcomes after Phacoemulsification with Intraocular Implantation surgeries among patients with and without Diabetes Mellitus. Med J Malaysia. 2021;76(2).
Grzybowski A, Kanclerz P, Huerva V, Ascaso FJ, Tuuminen R. Diabetes and Phacoemulsification Cataract Surgery: Difficulties, Risks and Potential Complications. J Clin Med. 2019;8(5). doi:10.3390/JCM8050716
Ilyas HS, Yulianti SR. Ilmu Penyakit Mata. 5th ed. Fakultas Kedokteran Universitas Indonesia; 2018. Accessed October 20, 2022.
Detty AU, Artini I, Yulian VR. Karakteristik Faktor Risiko Penderita Katarak. Jurnal Ilmiah Kesehatan Sandi Husada. 2021;10(1):12-17. doi:10.35816/jiskh.v10i1.494
Rita N. Hubungan Jenis Kelamin, Olah Raga dan Obesitas dengan Kejadian Diabetes Mellitus Pada Lansia. Jurnal Ilmu Kesehatan. 2018;2(1).
Soeprajogo MP. Cystoid Macular Edema Pasca Operasi Katarak. Universitas Padjadjaran; 2018.
Chen XY, Song WJ, Cai HY, Zhao L. Macular edema after cataract surgery in diabetic eyes evaluated by optical coherence tomography. Int J Ophthalmol. 2016;9(1):81. doi:10.18240/IJO.2016.01.14
Siswoyo, Hakam M, Purnami MES. The Correlations Between The Implementation of Discharge Planning with Treatment Complianceon Client Postoperative Cataract in RSD Dr. Soebandi Jember.; 2016.
Riordan-Eva P, Augsburger JJ. Vaughan & Asbury’s General Ophtalmology. 19th ed. McGraw Hill; 2017.
Hanis N, Mayani G, Hanina. Gambaran Perbaikan Visus Serta Komplikasi Intraoperasi atau Pascaoperasi Pada Pasien Operasi Katarak Senilis di RSUD H. Abdul Manap Kota Jambi Periode Januari 2021-Desember 2021. Journal of Medical Studies. 2023.;3(1)
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Danti Hasanah Fatmawati, Imam Masduki, Windy Aristiani
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
License and Copyright Agreement
In submitting the manuscript to the journal, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal. Please also carefully read Ahmad Dahlan Medical Journal posting Your Article Policy.
- That it is not under consideration for publication elsewhere.
- That its publication has been approved by all the author(s) and by the responsible authorities - tacitly or explicitly - of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
Copyright
Authors who publish with Ahmad Dahlan Medical Journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
